Michael Goldberg, President & CEO of Navidea Biopharmaceuticals, Inc. 00:00:00

Share On Facebook Share On Twitter

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

Recent Videos